Literature DB >> 28959949

Parkinson disease repurposing promise.

Asher Mullard.   

Abstract

Entities:  

Year:  2017        PMID： 28959949     DOI： 10.1038/nrd.2017.198

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  11 in total

Review 1.  Recent advances and discoveries in the mechanisms and functions of CAR T cells.

Authors:  Rebecca C Larson; Marcela V Maus
Journal:  Nat Rev Cancer       Date:  2021-01-22       Impact factor: 60.716

2.  Nutritional status alterations after chimeric antigen receptor T cell therapy in patients with hematological malignancies: a retrospective study.

Authors:  Shuyi Ding; Lingxia Cai; Aiyun Jin; Xiaoyu Zhou; Jiali Yan; Linqin Wang; Houli Zhao; Tingting Wang; Yongxian Hu
Journal:  Support Care Cancer       Date:  2022-01-05       Impact factor: 3.603

Review 3.  CAR-based therapies: opportunities for immuno-medicine beyond cancer.

Authors:  Haig Aghajanian; Joel G Rurik; Jonathan A Epstein
Journal:  Nat Metab       Date:  2022-02-28

4.  Generation of CAR-T Cells with Sleeping Beauty Transposon Gene Transfer.

Authors:  Sabrina Prommersberger; Razieh Monjezi; Lacramioara Botezatu; Csaba Miskey; Maximilian Amberger; Michael Hudecek; Zoltán Ivics; Katrin Mestermann
Journal:  Methods Mol Biol       Date:  2022

5.  Anti-mesothelin CAR-T immunotherapy in patients with ovarian cancer.

Authors:  Jiannan Chen; Jianhua Hu; Lili Gu; Feng Ji; Fan Zhang; Miaomiao Zhang; Jun Li; Zhengliang Chen; Longwei Jiang; Yan Zhang; Ruifang Shi; Lihua Ma; Shaochang Jia; Ying Zhang; Qi Zhang; Junqing Liang; Shunyu Yao; Zhigang Hu; Zhigang Guo
Journal:  Cancer Immunol Immunother       Date:  2022-08-04       Impact factor: 6.630

Review 6.  CAR T cells redirected against tumor-specific antigen glycoforms: can low-sugar antigens guarantee a sweet success?

Authors:  Pooria Safarzadeh Kozani; Pouya Safarzadeh Kozani; Fatemeh Rahbarizadeh
Journal:  Front Med       Date:  2022-06-10       Impact factor: 9.927

Review 7.  Cellular networks controlling T cell persistence in adoptive cell therapy.

Authors:  Jack D Chan; Junyun Lai; Clare Y Slaney; Axel Kallies; Paul A Beavis; Phillip K Darcy
Journal:  Nat Rev Immunol       Date:  2021-04-20       Impact factor: 53.106

Review 8.  Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy.

Authors:  Xiao Han; Yao Wang; Jianshu Wei; Weidong Han
Journal:  J Hematol Oncol       Date:  2019-11-29       Impact factor: 17.388

9.  CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity.

Authors:  Bryan D Choi; Xiaoling Yu; Ana P Castano; Amanda A Bouffard; Andrea Schmidts; Rebecca C Larson; Stefanie R Bailey; Angela C Boroughs; Matthew J Frigault; Mark B Leick; Irene Scarfò; Curtis L Cetrulo; Shadmehr Demehri; Brian V Nahed; Daniel P Cahill; Hiroaki Wakimoto; William T Curry; Bob S Carter; Marcela V Maus
Journal:  Nat Biotechnol       Date:  2019-07-22       Impact factor: 54.908

Review 10.  Bi-specific and tri-specific antibodies- the next big thing in solid tumor therapeutics.

Authors:  Karie Runcie; Daniel R Budman; Veena John; Nagashree Seetharamu
Journal:  Mol Med       Date:  2018-09-24       Impact factor: 6.354
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.